Hepatocellular Carcinoma

• CLINICAL_TRIALS withdrawal · 2012-06-11
  Clinical Trial Update: Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma [Phase 3]

  A Phase 3 trial comparing Transarterial Chemoembolization (TACE) versus CyberKnife for recurrent hepatocellular carcinoma has been withdrawn…

• CLINICAL_TRIALS withdrawal · 2012-06-07
  Clinical Trial Update: TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC) [Phase 2]

  A Phase 2 trial evaluating transarterial chemoembolization with sorafenib for advanced hepatocellular carcinoma was terminated.

• CLINICAL_TRIALS withdrawal · 2012-05-23
  Clinical Trial Update: Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis [Phase 1]

  Phase 1 trial of sorafenib for locally advanced or metastatic liver cancer in patients with cirrhosis has been terminated.

• CLINICAL_TRIALS withdrawal · 2012-04-18
  Clinical Trial Update: Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant [Phase 2]

  A Phase 2 trial evaluating stereotactic body radiation therapy for unresectable primary liver cancers, including hepatocellular carcinoma, h…

• CLINICAL_TRIALS withdrawal · 2012-02-20
  Clinical Trial Update: Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC) [Phase 3]

  A Phase 3 trial comparing transarterial chemoembolization (TACE) to CyberKnife for recurrent hepatocellular carcinoma has been withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2011-12-20
  Clinical Trial Update: A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. [Phase 1]

  A Phase 1 clinical trial evaluating crizotinib in combination with a VEGF inhibitor for advanced solid tumors has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2011-11-09
  Clinical Trial Update: Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients [Phase 3]

  A Phase 3 trial evaluating adding oxaliplatin and capecitabine to sorafenib versus sorafenib alone for advanced hepatocellular carcinoma has…

• CLINICAL_TRIALS withdrawal · 2009-03-19
  Clinical Trial Update: Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function

  The clinical trial evaluating bone marrow-derived adult liver stem cell recruitment after major liver resections and its correlation with li…

• CLINICAL_TRIALS withdrawal · 2008-12-15
  Clinical Trial Update: A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma [Phase 1, Phase 2]

  A Phase 1/2 study evaluating ADH300004 in combination with 5-Fluorouracil for hepatocellular carcinoma was terminated.

• CLINICAL_TRIALS withdrawal · 2008-08-29
  Clinical Trial Update: A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

  A Phase 1/2 study of LY2181308 for advanced hepatocellular carcinoma has been withdrawn.